NCT05973175

REFUEL PCOS Study 1

The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (The REFUEL PCOS) Study 1
Royal College of Surgeons, Ireland·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Polycystic Ovary Syndrome
Study type
Observational
Sponsor & location
Primary sponsor
Royal College of Surgeons, Ireland
Location
Dublin, Ireland
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Oct 01, 2025
Enrollment
40 participants
Primary outcome

To delineate the relationship between androgen excess and skeletal muscle energy metabolism in women

Summary

Polycystic Ovary Syndrome (PCOS) affects 10% of all women, and it usually co-exists with high
 levels of male pattern hormones (also termed androgens). Women with PCOS are at increased
 risk of metabolic complications such as diabetes, non-alcoholic fatty liver disease, high
 blood pressure and heart disease. However, very little is understood about how androgen
 excess results in increased metabolic complications observed in women with PCOS.
 
 The main aims of the REFUEL PCOS study are to compare markers of energy metabolism in women
 with PCOS to those without PCOS. This will allow us to better understand metabolic risk by
 examining the relationship between androgen excess and energy metabolism. Skeletal muscle is
 an important site of energy metabolism, and emerging theories are that androgen excess
 impairs skeletal muscle energy balance and increases the risk of complications. Based on
 these emerging theories, we want to investigate the effects of androgens on muscle energy
 metabolism. We will also examine whether certain blood and urine result patterns can help
 identify differences in muscles energy metabolism and which women are at the highest risk of
 metabolic complications. This research will give insight into the metabolic risk associated
 with PCOS and treat and, where possible, prevent the development of metabolic disease in
 affected women.

ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionNeoplasm of uncertain or unknown behaviour: Ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05973175
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05973175 through Pure Global AI's free database. This phase not specified trial is sponsored by Royal College of Surgeons, Ireland and is currently Not yet recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.